🇺🇸 FDA
Patent

US 9365823

Virus clearance of neoplastic cells from mixed cellular compositions

granted A61KA61K35/28A61K35/761

Quick answer

US patent 9365823 (Virus clearance of neoplastic cells from mixed cellular compositions) held by ONCOLYTICS BIOTECH INC. expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ONCOLYTICS BIOTECH INC.
Grant date
Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
42
CPC classes
A61K, A61K35/28, A61K35/761, A61K35/768, A61P